Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


Articles published in Int J Gynecol Cancer

Retrieve available abstracts of 113 articles:
HTML format
Text format



Single Articles


    October 2017
  1. KIYOTOKI T, Nakamura K, Haraga J, Omichi C, et al
    Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy.
    Int J Gynecol Cancer. 2017 Oct 17. doi: 10.1097/IGC.0000000000001127.
    PubMed     Text format     Abstract available


  2. WEI WF, Han LF, Liu D, Wu LF, et al
    Orthotopic Xenograft Mouse Model of Cervical Cancer for Studying the Role of MicroRNA-21 in Promoting Lymph Node Metastasis.
    Int J Gynecol Cancer. 2017;27:1587-1595.
    PubMed     Text format     Abstract available


  3. HILLESHEIM I, Limone GA, Klimann L, Monego H, et al
    Cervical Cancer Posttreatment Follow-up: Critical Analysis.
    Int J Gynecol Cancer. 2017;27:1747-1752.
    PubMed     Text format     Abstract available


    September 2017
  4. AL-HARBI NM, Bin Judia SS, Mishra KN, Shoukri MM, et al
    Genetic Predisposition to Cervical Cancer and the Association With XRCC1 and TGFB1 Polymorphisms.
    Int J Gynecol Cancer. 2017 Sep 13. doi: 10.1097/IGC.0000000000001103.
    PubMed     Text format     Abstract available


  5. TAKIUCHI T, Machida H, Hom MS, Mostofizadeh S, et al
    Association of Metformin Use and Survival Outcome in Women With Cervical Cancer.
    Int J Gynecol Cancer. 2017;27:1455-1463.
    PubMed     Text format     Abstract available


    August 2017
  6. NIE JC, Yan AQ, Liu XS
    Robotic-Assisted Radical Hysterectomy Results in Better Surgical Outcomes Compared With the Traditional Laparoscopic Radical Hysterectomy for the Treatment of Cervical Cancer.
    Int J Gynecol Cancer. 2017 Aug 31. doi: 10.1097/IGC.0000000000001101.
    PubMed     Text format     Abstract available


    July 2017
  7. LUCIDI A, Windemut S, Petrillo M, Dessole M, et al
    Self-Reported Long-Term Autonomic Function After Laparoscopic Total Mesometrial Resection for Early-Stage Cervical Cancer: A Multicentric Study.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001045.
    PubMed     Text format     Abstract available


  8. CHANTALAT E, Vidal F, Motton S
    Letter to the Editor on "Management of Para-aortic Lymph Node Disease in Patients With Cervical Cancer": What is the Best Approach? Int J Gynecol Cancer. 2017 Mar; 27(3): 543549.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001085.
    PubMed     Text format    


  9. NARTEY Y, Hill PC, Amo-Antwi K, Nyarko KM, et al
    Factors Contributing to the Low Survival Among Women With a Diagnosis of Invasive Cervical Cancer in Ghana.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001088.
    PubMed     Text format     Abstract available


  10. PANG T, Li M, Zhang Y, Yong W, et al
    Y Box-Binding Protein 1 Promotes Epithelial-Mesenchymal Transition, Invasion, and Metastasis of Cervical Cancer via Enhancing the Expressions of Snail.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001066.
    PubMed     Text format     Abstract available


  11. VAN GENT MDJM, Rademaker M, van der Veer JCB, van Poelgeest MIE, et al
    Long-Term Oncological Outcome After Conventional Radical Hysterectomy Versus 2 Nerve-Sparing Modalities for Early Stage Cervical Cancer.
    Int J Gynecol Cancer. 2017 Jul 12. doi: 10.1097/IGC.0000000000001067.
    PubMed     Text format     Abstract available


  12. MACHIDA H, Eckhardt SE, Antonio C, Blake EA, et al
    Single Marital Status and Infectious Mortality in Women With Cervical Cancer in the United States.
    Int J Gynecol Cancer. 2017 Jul 12. doi: 10.1097/IGC.0000000000001068.
    PubMed     Text format     Abstract available


  13. ZHU T, Chen X, Zhu J, Chen Y, et al
    Surgical and Pathological Outcomes of Laparoscopic Versus Abdominal Radical Hysterectomy With Pelvic Lymphadenectomy and/or Para-aortic Lymph Node Sampling for Bulky Early-Stage Cervical Cancer.
    Int J Gynecol Cancer. 2017;27:1222-1227.
    PubMed     Text format     Abstract available


    June 2017
  14. SONG MK, Shin BS, Ha CS, Park WY, et al
    Would Lipophilic Statin Therapy as a Prognostic Factor Improve Survival in Patients With Uterine Cervical Cancer?
    Int J Gynecol Cancer. 2017 Jun 23. doi: 10.1097/IGC.0000000000001046.
    PubMed     Text format     Abstract available


  15. CANAZ E, Ozyurek ES, Erdem B, Aldikactioglu Talmac M, et al
    Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer.
    Int J Gynecol Cancer. 2017 Jun 14. doi: 10.1097/IGC.0000000000001060.
    PubMed     Text format     Abstract available


  16. POKA R, Molnar S, Darago P, Lukacs J, et al
    Intention-to-Treat Analysis of Radical Trachelectomy for Early-Stage Cervical Cancer With Special Reference to Oncologic Failures: Single-Institutional Experience in Hungary.
    Int J Gynecol Cancer. 2017 Jun 10. doi: 10.1097/IGC.0000000000001048.
    PubMed     Text format     Abstract available


  17. GULER OC, Sari SY, Birgi SD, Gultekin M, et al
    Definitive Chemoradiotherapy in Elderly Cervical Cancer Patients: A Multiinstitutional Analysis.
    Int J Gynecol Cancer. 2017 Jun 10. doi: 10.1097/IGC.0000000000001029.
    PubMed     Text format     Abstract available


  18. ECHEVERRIA A, Manley H, O'Donnell B, Asper J, et al
    Factors Associated With Radiation Treatment Compliance for Women With Cervical Cancer in a Safety Net Health System.
    Int J Gynecol Cancer. 2017 Jun 10. doi: 10.1097/IGC.0000000000001035.
    PubMed     Text format     Abstract available


  19. SALIHI R, Leunen K, Moerman P, Amant F, et al
    Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer.
    Int J Gynecol Cancer. 2017 Jun 1. doi: 10.1097/IGC.0000000000001021.
    PubMed     Text format     Abstract available


    May 2017
  20. DERKS M, Groenman FA, van Lonkhuijzen LRCW, Schut PC, et al
    Completing or Abandoning Radical Hysterectomy in Early-Stage Lymph Node-Positive Cervical Cancer: Impact on Disease-Free Survival and Treatment-Related Toxicity.
    Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000974.
    PubMed     Text format     Abstract available


  21. BAKKER RM, Pieterse QD, van Lonkhuijzen LRCW, Trimbos BJBMZ, et al
    A Controlled Study on Vaginal Blood Flow During Sexual Arousal Among Early-Stage Cervical Cancer Survivors Treated With Conventional Radical or Nerve-Sparing Surgery With or Without Radiotherapy.
    Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000986.
    PubMed     Text format     Abstract available


  22. PLANTE M, Renaud MC, Sebastianelli A, Gregoire J, et al
    Simple Vaginal Trachelectomy: A Valuable Fertility-Preserving Option in Early-Stage Cervical Cancer.
    Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000989.
    PubMed     Text format     Abstract available


  23. ZHENG RR, Huang XW, Liu WY, Lin RR, et al
    Nomogram Predicting Overall Survival in Operable Cervical Cancer Patients.
    Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000987.
    PubMed     Text format     Abstract available


  24. TOMAO F, Maruccio M, Preti EP, Boveri S, et al
    Conization in Early Stage Cervical Cancer: Pattern of Recurrence in a 10-Year Single-Institution Experience.
    Int J Gynecol Cancer. 2017 May 8. doi: 10.1097/IGC.0000000000000991.
    PubMed     Text format     Abstract available


  25. WEN Q, Liu Y, Lyu H, Xu X, et al
    Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
    Int J Gynecol Cancer. 2017 May 2. doi: 10.1097/IGC.0000000000001028.
    PubMed     Text format     Abstract available


    April 2017
  26. ROSEN VM, Guerra I, McCormack M, Nogueira-Rodrigues A, et al
    Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non-Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer.
    Int J Gynecol Cancer. 2017 Apr 26. doi: 10.1097/IGC.0000000000001000.
    PubMed     Text format     Abstract available


    March 2017
  27. ZHANG Y, Gao H, Gao X, Huang S, et al
    Elevated Expression of Kin17 in Cervical Cancer and Its Association With Cancer Cell Proliferation and Invasion.
    Int J Gynecol Cancer. 2017 Mar 24. doi: 10.1097/IGC.0000000000000928.
    PubMed     Text format     Abstract available


  28. LEE JW, Jeon S, Mun ST, Lee SM, et al
    Prognostic Value of Fluorine-18 Fluorodeoxyglucose Uptake of Bone Marrow on Positron Emission Tomography/Computed Tomography for Prediction of Disease Progression in Cervical Cancer.
    Int J Gynecol Cancer. 2017 Mar 23. doi: 10.1097/IGC.0000000000000949.
    PubMed     Text format     Abstract available


  29. WANG Q, Wei Y, Zhang J
    Combined Knockdown of D-dopachrome Tautomerase and Migration Inhibitory Factor Inhibits the Proliferation, Migration, and Invasion in Human Cervical Cancer.
    Int J Gynecol Cancer. 2017 Mar 23. doi: 10.1097/IGC.0000000000000951.
    PubMed     Text format     Abstract available


  30. LIU ZS, Guo J, Zhao YZ, Lin X, et al
    Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Int J Gynecol Cancer. 2017 Mar 6. doi: 10.1097/IGC.0000000000000929.
    PubMed     Text format     Abstract available


    February 2017
  31. GUBBI A, Kacheria S, Ahmad S, Stavitzski NM, et al
    Prognostic Significance of the Standardized Uptake Value of Pretherapeutic 18F-Labeled 2-Fluoro-2-Deoxyglucose Positron Emission Tomography/Computed Tomography in Patients With Locally Advanced Cervical Cancer.
    Int J Gynecol Cancer. 2017 Feb 10. doi: 10.1097/IGC.0000000000000930.
    PubMed     Text format     Abstract available


  32. MABUCHI S, Kimura T
    Extraperitoneal Radical Trachelectomy With Pelvic Lymphadenectomy: A Novel Fertility-Preserving Option for Early Stage Cervical Cancer Patients.
    Int J Gynecol Cancer. 2017 Feb 10. doi: 10.1097/IGC.0000000000000918.
    PubMed     Text format     Abstract available


  33. KOENSGEN D, Sehouli J, Belau A, Weiss M, et al
    Clinical Outcome of Neoadjuvant Radiochemotherapy in Locally Advanced Cervical Cancer: Results of an Open Prospective, Multicenter Phase 2 Study of the North-Eastern German Society of Gynecological Oncology.
    Int J Gynecol Cancer. 2017 Feb 10. doi: 10.1097/IGC.0000000000000894.
    PubMed     Text format     Abstract available


  34. PETITNICOLAS C, Azais H, Ghesquiere L, Tresch-Bruneel E, et al
    Morbidity of Staging Inframesenteric Paraaortic Lymphadenectomy in Locally Advanced Cervical Cancer Compared With Infrarenal Lymphadenectomy.
    Int J Gynecol Cancer. 2017 Feb 4. doi: 10.1097/IGC.0000000000000921.
    PubMed     Text format     Abstract available


  35. KIM M, Suh DH, Kim K, Lee HJ, et al
    Magnetic Resonance Imaging as a Valuable Tool for Predicting Parametrial Invasion in Stage IB1 to IIA2 Cervical Cancer.
    Int J Gynecol Cancer. 2017;27:332-338.
    PubMed     Text format     Abstract available


    January 2017
  36. YANG K, Park W, Huh SJ, Park BK, et al
    Parametrial Involvement on Magnetic Resonance Imaging Has No Effect on the Survival of Early-Stage Cervical Cancer Patients.
    Int J Gynecol Cancer. 2017 Jan 26. doi: 10.1097/IGC.0000000000000909.
    PubMed     Text format     Abstract available


  37. BOGANI G, Ditto A, Martinelli F, Signorelli M, et al
    Impact of Blood Transfusions on Survival of Locally Advanced Cervical Cancer Patients Undergoing Neoadjuvant Chemotherapy Plus Radical Surgery.
    Int J Gynecol Cancer. 2017 Jan 26. doi: 10.1097/IGC.0000000000000902.
    PubMed     Text format     Abstract available


  38. NEGRAO MV, Lima JM, Silva SC, Diz MD, et al
    Management of Para-aortic Lymph Node Disease in Patients With Cervical Cancer: What Is the Best Approach?
    Int J Gynecol Cancer. 2017 Jan 19. doi: 10.1097/IGC.0000000000000914.
    PubMed     Text format     Abstract available


    December 2016
  39. SASAKI Y, Iwanari O, Arakawa I, Moriya T, et al
    Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan.
    Int J Gynecol Cancer. 2016 Dec 16. doi: 10.1097/IGC.0000000000000898.
    PubMed     Text format     Abstract available


  40. CHEN X, Zou H, Li H, Lin R, et al
    Weekly Versus Triweekly Cisplatin-Based Chemotherapy Concurrent With Radiotherapy in the Treatment of Cervical Cancer: A Meta-Analysis.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  41. DERKS M, van Lonkhuijzen LR, Bakker RM, Stiggelbout AM, et al
    Long-Term Morbidity and Quality of Life in Cervical Cancer Survivors: A Multicenter Comparison Between Surgery and Radiotherapy as Primary Treatment.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  42. GRAVES S, Seagle BL, Strohl AE, Shahabi S, et al
    Survival After Pelvic Exenteration for Cervical Cancer: A National Cancer Database Study.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  43. KIM YJ, Kim BR, Ryu JS, Lee GO, et al
    HNRNPA1, a Splicing Regulator, Is an Effective Target Protein for Cervical Cancer Detection: Comparison With Conventional Tumor Markers.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  44. EMMETT M, Gildea C, Nordin A, Hirschowitz L, et al
    Variations in Treatment of Cervical Cancer According to Tumor Morphology-Population-Based Cohort Analysis of English National Cancer Registration Data.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


    November 2016
  45. HANPRASERTPONG J, Jiamset I, Geater A, Peerawong T, et al
    The Effect of Metformin on Oncological Outcomes in Patients With Cervical Cancer With Type 2 Diabetes Mellitus.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  46. SUN P, Shen Y, Gong JM, Zhou LL, et al
    A New MicroRNA Expression Signature for Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


    October 2016
  47. DIAB Y
    Sentinel Lymph Nodes Mapping in Cervical Cancer a Comprehensive Review.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


    September 2016
  48. NAKAMURA K, Masuyama H, Ida N, Haruma T, et al
    Radical Hysterectomy Plus Concurrent Chemoradiation/Radiation Therapy Is Negatively Associated With Return to Work in Patients With Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  49. LEE KC, Kim HJ, Sung K, Choi YE, et al
    The Predictive Value of Tumor Size, Volume, and Markers During Radiation Therapy in Patients With Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  50. ZUSTERZEEL PL, Pol FJ, van Ham M, Zweemer RP, et al
    Vaginal Radical Trachelectomy for Early-Stage Cervical Cancer: Increased Recurrence Risk for Adenocarcinoma.
    Int J Gynecol Cancer. 2016;26:1293-9.
    PubMed     Text format     Abstract available


  51. RYCHLIK A, Marin S, De Santiago J, Zapardiel I, et al
    Utility of Laparoscopic Indocyanine Green-Guided Sentinel Node Biopsy in Open Cervical Cancer Surgery.
    Int J Gynecol Cancer. 2016;26:1288-9.
    PubMed     Text format     Abstract available


  52. MABUCHI S, Yokoi E, Owa T, Kozasa K, et al
    Phase I Clinical Study of Irinotecan Plus S-1 in Patients With Advanced or Recurrent Cervical Cancer Previously Treated With Platinum-Based Chemotherapy.
    Int J Gynecol Cancer. 2016;26:1281-7.
    PubMed     Text format     Abstract available


  53. WANG W, Chu HJ, Shang CL, Gong X, et al
    Long-Term Oncological Outcomes After Laparoscopic Versus Abdominal Radical Hysterectomy in Stage IA2 to IIA2 Cervical Cancer: A Matched Cohort Study.
    Int J Gynecol Cancer. 2016;26:1264-73.
    PubMed     Text format     Abstract available


    August 2016
  54. RICCI C, Scambia G, De Vincenzo R
    Locally Advanced Cervical Cancer in Pregnancy: Overcoming the Challenge. A Case Series and Review of the Literature.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


    July 2016
  55. KHATIB G, Kucukgoz Gulec U, Baris Guzel A, Uygur B, et al
    A Single-Institution Radical Surgery Results in Stage IB2/IIA2 (Bulky) Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  56. DERKS M, van der Velden J, Frijstein MM, Vermeer WM, et al
    Long-term Pelvic Floor Function and Quality of Life After Radical Surgery for Cervical Cancer: A Multicenter Comparison Between Different Techniques for Radical Hysterectomy With Pelvic Lymphadenectomy.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  57. KIM DH, Kim WT, Bae JS, Ki YK, et al
    Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiothe
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  58. NOGUEIRA-RODRIGUES A, Melo AC, Garces AH, Paulino E, et al
    Patterns of Care and Outcome of Elderly Women Diagnosed With Cervical Cancer in the Developing World.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  59. ZHANG S, Wang S, Lv A, Huang S, et al
    Laparoscopically Assisted Radical Vaginal Hysterectomy for Early-Stage Cervical Cancer: A Systemic Review and Meta-Analysis.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  60. MARTINEZ-FERNANDEZ MI, Legaspi Folgueira J, Valtuena Peydro G, Cambeiro M, et al
    Long-Term Results of a Phase II Trial of Concomitant Cisplatin-Paclitaxel Chemoradiation in Locally Advanced Cervical Cancer.
    Int J Gynecol Cancer. 2016;26:1162-8.
    PubMed     Text format     Abstract available


    June 2016
  61. YOON A, Park JJ, Park BK, Lee YY, et al
    Long-term Outcomes of MRI Stage IIB Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  62. UJIHIRA T, Ota T, Kusunoki S, Sugimori Y, et al
    Outcome of Neoadjuvant Intra-Arterial Chemotherapy and Radical Hysterectomy for Treatment of Bulky Stage IB to Stage IIB Uterine Cervical Cancer: Can Postoperative Irradiation Be Avoided?
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  63. GUBBALA PK, Laios A, Wang Z, Dhar S, et al
    Routine Intraoperative Frozen Section Examination to Minimize Bimodal Treatment in Early-Stage Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  64. YU X, Zhao W, Yang X, Wang Z, et al
    miR-375 Affects the Proliferation, Invasion, and Apoptosis of HPV16-Positive Human Cervical Cancer Cells by Targeting IGF-1R.
    Int J Gynecol Cancer. 2016;26:851-8.
    PubMed     Text format     Abstract available


  65. ZHOU Q, Han LR, Zhou YX, Li Y, et al
    MiR-195 Suppresses Cervical Cancer Migration and Invasion Through Targeting Smad3.
    Int J Gynecol Cancer. 2016;26:817-24.
    PubMed     Text format     Abstract available


    May 2016
  66. ONAL C, Guler OC, Yildirim BA
    Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  67. YANG F, Young L, Grigsby P
    Predictive Value of Standardized Intratumoral Metabolic Heterogeneity in Locally Advanced Cervical Cancer Treated With Chemoradiation.
    Int J Gynecol Cancer. 2016;26:777-784.
    PubMed     Text format     Abstract available


    April 2016
  68. EIBYE S, Kruger Kjaer S, Nielsen TS, Mellemkjaer L, et al
    Mortality Among Women With Cervical Cancer During or Shortly After a Pregnancy in Denmark 1968 to 2006.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  69. ZHANG L, Zhan X, Yan D, Wang Z, et al
    Circulating MicroRNA-21 Is Involved in Lymph Node Metastasis in Cervical Cancer by Targeting RASA1.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  70. PHIPPEN NT, Havrilesky LJ, Barnett JC, Hamilton CA, et al
    Does Routine Posttreatment PET/CT Add Value to the Care of Women With Locally Advanced Cervical Cancer?
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  71. DUTTA S, Singh RK, Mandal RK, Roychoudhury S, et al
    Alteration of Human Papillomavirus Type 16 Genetic and Epigenetic Profiles in Cervical Cancer Patients Is Indicative of Poor Disease Prognosis: A Cohort Analysis.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


    March 2016
  72. BAE HS, Kim YJ, Lim MC, Seo SS, et al
    Predictors of Radiation Field Failure After Definitive Chemoradiation in Patients With Locally Advanced Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  73. ABDALLAH R, Bush SH, Chon HS, Apte SM, et al
    Therapeutic Dilemma: Prognostic Factors and Outcome for Neuroendocrine Tumors of the Cervix.
    Int J Gynecol Cancer. 2016;26:553-60.
    PubMed     Text format     Abstract available


  74. SATO S, Shimada M, Ohta T, Kojimahara T, et al
    Feasibility Study of Adjuvant Chemotherapy Using Taxane Plus Carboplatin for High-Risk Patients With Uterine Cervical Non-Squamous Cell Carcinoma After Radical Hysterectomy.
    Int J Gynecol Cancer. 2016;26:561-7.
    PubMed     Text format     Abstract available


  75. HAO M, Wang Z, Wei F, Wang J, et al
    Cavitron Ultrasonic Surgical Aspirator in Laparoscopic Nerve-Sparing Radical Hysterectomy: A Pilot Study.
    Int J Gynecol Cancer. 2016;26:594-9.
    PubMed     Text format     Abstract available


  76. ALCAZAR JL, Arribas S, Martinez-Monge R, Jurado M, et al
    Three-Dimensional Power Doppler Ultrasound for Predicting Response and Local Recurrence After Concomitant Chemoradiation Therapy for Locally Advanced Carcinoma of the Cervix.
    Int J Gynecol Cancer. 2016;26:534-8.
    PubMed     Text format     Abstract available


    February 2016
  77. XIE X, Song K, Cui B, Jiang J, et al
    Significance of the Factors Associated With Parametrial Involvement in Stage IB to IIA Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  78. GONG L, Zhang JW, Yin RT, Wang P, et al
    Safety and Efficacy of Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Radical Surgery Alone in Locally Advanced Cervical Cancer Patients.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  79. KIM MK, Sim JA, Yun YH, Bae DS, et al
    Health-Related Quality of Life and Sociodemographic Characteristics as Prognostic Indicators of Long-term Survival in Disease-Free Cervical Cancer Survivors.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  80. KOTSOPOULOS IC, Kucukmetin A, Mukhopadhyay A, Lunec J, et al
    Poly(ADP-Ribose) Polymerase in Cervical Cancer Pathogenesis: Mechanism and Potential Role for PARP Inhibitors.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  81. CHANG Y, Yang ZY, Li GL, Li Q, et al
    Correlations Between Radiation Dose in Bone Marrow and Hematological Toxicity in Patients With Cervical Cancer: A Comparison of 3DCRT, IMRT, and RapidARC.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  82. DHULL VS, Khangembam BC, Sharma P, Rana N, et al
    Surgical Scar Site Recurrence in Patients With Cervical Cancer on 18F-FDG PET-CT: A Case-Control Study.
    Int J Gynecol Cancer. 2016;26:354-60.
    PubMed     Text format     Abstract available


  83. ZHOU G, Chen X, Tang F, Zhou J, et al
    The Value of Diffusion-Weighted Imaging in Predicting the Prognosis of Stage IB-IIA Cervical Squamous Cell Carcinoma After Radical Hysterectomy.
    Int J Gynecol Cancer. 2016;26:361-6.
    PubMed     Text format     Abstract available


  84. VRANES B, Milenkovic S, Radojevic M, Soldatovic I, et al
    Risk of Parametrial Spread in Small Stage I Cervical Carcinoma: Pathology Review of 223 Cases With a Tumor Diameter of 20 mm or Less.
    Int J Gynecol Cancer. 2016;26:416-21.
    PubMed     Text format     Abstract available


    January 2016
  85. ZANAGNOLO V, Minig L, Rollo D, Tomaselli T, et al
    Clinical and Oncologic Outcomes of Robotic Versus Abdominal Radical Hysterectomy for Women With Cervical Cancer: Experience at a Referral Cancer Center.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  86. CORRADO G, Cutillo G, Saltari M, Mancini E, et al
    Surgical and Oncological Outcome of Robotic Surgery Compared With Laparoscopic and Abdominal Surgery in the Management of Locally Advanced Cervical Cancer After Neoadjuvant Chemotherapy.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  87. SIESTO G, Romano F, Accardi A, Bulletti C, et al
    Robotic Surgery in Patients With Locally Advanced Cervical Cancer After Neoadjuvant Chemotherapy: Survival Outcomes.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  88. SASANO T, Mabuchi S, Kuroda H, Takahashi R, et al
    Predictors of Survival in Patients With FIGO Stage IVB Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  89. LATERZA RM, Uccella S, Casarin J, Morosi C, et al
    Recurrence of Early Stage Cervical Cancer After Laparoscopic Versus Open Radical Surgery.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  90. LINDSAY R, Burton K, Shanbhag S, Millan D, et al
    Reply to the "Letter to the Editor re: Fertility Conserving Management of Early Cervical Cancer: Our Experience of LLETZ and Pelvic Lymph Node Dissection" by Dr. MK Mehasseb (Int J Gynecol Cancer. 2015;25:2-3).
    Int J Gynecol Cancer. 2016;26:34.
    PubMed     Text format    


  91. LEBLANC E, Katdare N, Narducci F, Bresson L, et al
    Should Systematic Infrarenal Para-aortic Dissection Be the Rule in the Pretherapeutic Staging of Primary or Recurrent Locally Advanced Cervix Cancer Patients With a Negative Preoperative Para-aortic PET Imaging?
    Int J Gynecol Cancer. 2016;26:169-75.
    PubMed     Text format     Abstract available


  92. SHI R, Wei W, Jiang P
    Laparoscopic Nerve-Sparing Radical Hysterectomy for Cervical Carcinoma: Emphasis on Nerve Content in Removed Cardinal Ligaments.
    Int J Gynecol Cancer. 2016;26:192-8.
    PubMed     Text format     Abstract available


  93. KI EY, Lee KH, Hur SY, Rhee JE, et al
    Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.
    Int J Gynecol Cancer. 2016;26:176-83.
    PubMed     Text format     Abstract available


  94. CHANG WC, Li CH, Chu LH, Huang PS, et al
    Regulatory T Cells Suppress Natural Killer Cell Immunity in Patients With Human Cervical Carcinoma.
    Int J Gynecol Cancer. 2016;26:156-62.
    PubMed     Text format     Abstract available


    November 2015
  95. SAGAE S, Monk BJ, Pujade-Lauraine E, Gaffney DK, et al
    Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


    October 2015
  96. KASUGA Y, Nishio H, Miyakoshi K, Sato S, et al
    Pregnancy Outcomes After Abdominal Radical Trachelectomy for Early-Stage Cervical Cancer: A 13-Year Experience in a Single Tertiary-Care Center.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  97. KONG TW, Piao X, Chang SJ, Paek J, et al
    A Predictive Model for Parametrial Invasion in Patients With FIGO Stage IB Cervical Cancer: Individualized Approach for Primary Treatment.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  98. SALA E, Micco M, Burger IA, Yakar D, et al
    Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.
    Int J Gynecol Cancer. 2015;25:1461-7.
    PubMed     Text format     Abstract available


    September 2015
  99. KAWANO M, Mabuchi S, Matsumoto Y, Sasano T, et al
    Prognostic Significance of Pretreatment Thrombocytosis in Cervical Cancer Patients Treated With Definitive Radiotherapy.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  100. ZHOU X, Xu CJ, Wang JX, Dai T, et al
    Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


    August 2015
  101. HSIEH GL, Linesch S, Sajjad A, Macdonald A, et al
    Treatment Compliance and Outcomes for Women With Locoregionally Advanced Cervical Cancer Treated in a Safety Net Health System.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  102. CHEN X, Zhu B, Luo Y, Zhang D, et al
    Interleukin-28B Plays a Therapeutic Role on Mouse U14 Cervical Cancer Cells by Down-Regulating CD4+CD25+FoxP3+Regulatory T Cells In Vivo.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  103. MU X, Zhao J, Yuan X, Zhao X, et al
    Gene Polymorphisms of Toll-Like Receptor 9 -1486T/C and 2848G/A in Cervical Cancer Risk.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  104. BRADBURY M, Founta C, Taylor W, Kucukmetin A, et al
    Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


    July 2015
  105. BUDA A, Lissoni AA, Floriani I, Biagioli E, et al
    Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


    June 2015
  106. NISHIDA T, Nakamura K, Haraga J, Ogawa C, et al
    The Glasgow Prognostic Score Determined During Concurrent Chemoradiotherapy Is an Independent Predictor of Survival for Cervical Cancer.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  107. SIMONDS HM, Neugut AI, Jacobson JS
    HIV Status and Acute Hematologic Toxicity Among Patients With Cervix Cancer Undergoing Radical Chemoradiation.
    Int J Gynecol Cancer. 2015;25:884-90.
    PubMed     Text format     Abstract available


    May 2015
  108. JIANG E, Sun X, Kang H, Sun L, et al
    Dehydrocostus Lactone Inhibits Proliferation, Antiapoptosis, and Invasion of Cervical Cancer Cells Through PI3K/Akt Signaling Pathway.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  109. LIU Y, Ye Z, Sun H, Bai R, et al
    Clinical Application of Diffusion-Weighted Magnetic Resonance Imaging in Uterine Cervical Cancer.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  110. SCHNEIDER A, Kohler C
    Locoregional recurrence after laparoscopic radical trachelectomy: the vaginal cuff must be closed to avoid tumor cell contamination of the peritoneal cavity.
    Int J Gynecol Cancer. 2015;25:550.
    PubMed     Text format    


    March 2015
  111. ALTOBELLI E, Lattanzi A
    Cervical carcinoma in the European Union: an update on disease burden, screening program state of activation, and coverage as of March 2014.
    Int J Gynecol Cancer. 2015;25:474-83.
    PubMed     Text format     Abstract available


  112. SONG E, Yu W, Xiong X, Kuang X, et al
    Astrocyte elevated gene-1 promotes progression of cervical squamous cell carcinoma by inducing epithelial-mesenchymal transition via Wnt signaling.
    Int J Gynecol Cancer. 2015;25:345-55.
    PubMed     Text format     Abstract available


    February 2015
  113. FRANKE O, Narducci F, Chereau-Ewald E, Orsoni M, et al
    Role of a double docking to improve lymph node dissection: when robotically assisted laparoscopy for para-aortic lymphadenectomy is associated to a pelvic procedure.
    Int J Gynecol Cancer. 2015;25:331-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: